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Class II major histocompatibility molecules are cell recognition structures that,
in combination with processed foreign antigen, form the ligand for CD4+ T lym-
phocyte antigen receptors (1). The class 11 molecules consist ofan a and a 0 poly-
peptide, both ofwhich exhibit ahigh degree ofstructural polymorphism (2, 3). Since
Tcellantigenrecognitionisinfluenced bytheallelicorginofboth chains, additional
functional diversity is generated by combinatorial association of different a and 0
chain allelic products (4). Biochemical analyses of B lymphoma cell lines (5) and
L cells transfected with different a and [s alleles (6) have demonstrated that certain
Aa and Ap polypeptides do not form heterodimers effectively on the cell surface.
Studies using hybrid gene constructs suggested that amino acid differences in the
NH2-terminal halfof the ¢I domain are responsible for the pairing defects ofthese
a/(3 chain combinations (7, 8).
In this report we have analyzed a panel ofcell lines expressing mutant Ap (desig-
nated A4') polypeptides, which were produced by substituting one or more d allele
residues in the 01 domain (9), to identify AA polymorphic positions responsible for
the preferential association of A4 polypeptide with the Aa polypeptide rather than
with the Ad polypeptide. We have identified polymorphic positions in the NH2-
terminal part of the 01 domain that are responsible for this preferential chain as-
sociation. In addition, we have also identified mutations in the C001-1-terminal
end of the (i1 domain that either completely inhibit AD* Ad expression or result in
the expression ofthe Ap* Ad molecule primarily in an intracytoplasmic compart-
ment. These results suggest that the substitution at these polymorphic positions in
the NH2- and COOH-terminal ends ofthe 131 domain can alter cell surface expres-
sion ofcertain AD Aa molecules, resulting in limitation ofthe potential number of
different class 11 restriction molecules that can mediate antigen-specific TH cell ac-
ion. In addition, the resultsfrom thecharacterization ofone oftheseallele-specific
expression mutants suggest thatthe transport ofthe la molecules from the cytoplasm
tothecell surfacemaybe regulated by signalsthat aredetermined bytheinteraction
of polymorphic residues in both the R and a polypeptides.
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Materials and Methods
Cell Lines.
￿
The panel ofwild-type or mutant la-bearing bulk populations and cloned cell
lineswere prepared by transfecting into M12.C3 cells (generously provided by Dr. L. Glimcher,
Harvard Medical School, Boston, MA), plasmids containing the wild-type Afi' gene or mu-
tant Ap" genes, the neomycin resistance gene pRSVneo and, in certain cases, with the wild-
A k, gene as described previously (9). The transfected cells were cultured in RPMI 1640
medium (Gibco Laboratories, Grand Island, NY) supplemented with 1070 heat-inactivated
FCS, 100 U/ml penicillin, 100pg/ml streptomycin, 1 MM L-glutamine, 0.1 mM 2-ME, 10
mM Hepes, and 600 pg/mI G.418. Cells transfected with the pSV2-hygm gene were cultured
in the complete RPMI medium containing 600 peg/ml hygromycin.
Serologic Phenotypes.
￿
Expression of c
fluorescence with FITC protein A on a
monoclonal AD-reactive antibody, 40F (10
Q 001 39F (10), or 3102 Oy, or antiA$ antibody.,
DNA-mediated Gene Transfer. Mutant la-bearing cell lines were supertransfected with
plasmids containing the wild-type A* a gene and a hygromycin resistance marker. 10' cells were
mixed with 70 gg of a linearized plasmid containing the wild-type A gene (9) and 50 Itg
of the linearized pSV2-hygro plasmid (14) in 0.6 ml medium containing 140 mM NaCl, 25
mM Hepes, 0.75 mM Na2HP04, pH 7.4. Electroporation was carried out as described pre-
viously (9), The treated cells were cultured at 37'C for 16 h and then selected in medium
containing 600 gg/mlhygromycin B (Sigma Chemical Co., St. Louis, MO). Each bulk popu-
k k lation used for analysis of AD* AQ surface expression originated from at least 24 indepen-
dent hygronTain-resistant clones. Cell lines were cloned from the hygromycin-resistant bulk
populations by limiting dilution.
rthern Blot Analysis.
￿
Poly(A)' mRNA (10 Ag) from each cell line was size selected on
% agarose formaldehyde gel and transferred to Gene Screen Plus (New England Nu-
clear, Boston, MA) (15). Hybridization was performed using an A. synthetic al'
(sequence 269-246) derived from the noncoding strand of the A,*, gene (16), ar
probe (Eco RI fragment of pKAK [17]), Ak cDNA (Eco RI fragment of pKBK [16]) or actin
(p7OOO actin; Oncor). Blots were sequentially hybridized as previously described (18).
Biochemical Analysis ofIa Molecules. Proceduresfor the isolation ofintrinsically radiolabeled
la molecules from marine "11 lines have been described in detail in a previous report (5).
Briefly, the transfected M12.C3 cell lines were biosynthetically radiolabeled with ["S]methio-
nine, solubilized with a 0.517o Triton X-100-containing lysisbuffer and the Ia molecules were
immunoprecipitated from the cell lysate with either an A
k reactive mAb (10-2.16 [19], 40 M
[10]) or an isotype-matched control (CBIOI) bound to protein A-Sepharose. The immuno-
precipitates were analyzed by two-dimensional nonequilibrium pH gradient electrophoresis
as described previously (5).
face Ia molecules was quantitated by indirect
{FAGS IV) after staining with the
ibody, 34-5.3S (11), anti-A', antibodies,
199 (13) as previously reported (12).
Results
To investigate systematically the role ofpolymorphic residues in the
tide, we have constructed by site-directed mutagenesis a series of A0
k* genes encod-
ing single or multiple residues characteristic of the A~ allele in the Bt domain (9)
(Fig. 1). Each
￿
gene was transfected together with a wild-type A' and/or a neo-
mycin-resistance gene into the Ad expression-negative B lymphoma line M12.C3
(9). Since this cell line expresses functional Ad mRNA but not Ag mRNA, M12,C3 a
cells transfected with different combinations of A and/or Ap k genes together wi
neomycin-resistance marker can be used to test the ability ofAk polypeptides to as-
sociate with Ak or Ad a
￿
,, polypeptides. M12,C3 cells transfected with the wild-type A~
gene express A~ Ad molecules on their surface, while M12.C3 cells transfected with a
both wild-type A
kand Ak genes express primarily Af A~, molecules on their surface (9). 0 a
Cell Surface Expression ofA178 and M86 Ah* Mutants.
￿
la cell surface expression10 20 30 40 50 60 70 so 90
I
￿
I
￿
I
￿
I
￿
I
￿
I
k
￿
C
￿
VNQ POPFCIMG 2QRnUMM IYNRMYVRF DSDUCZYRAV TE[II2PDAEY IdIIRl Y UM 7RAELUIVLR L3tYEUETPr SIIdUE
d
E
U
V -IQZ-Y-
￿
T__
Region A
￿
Region H
￿
Regim C
￿
Region D
FIGURE 1.
￿
Amino acid sequences of the Ak andA$ 91 domains (32). Mutant A~*genes encoding
dallele residues at each ofthe 14 polymorphic positions, at multiple positions, or in polymorphic
regions ofthe 61 domain have been constructed by site-directed mutagenesis (9). Theboundaries
anddesignation chosen for these polymorphic regions are indicatedbelow the sequences. Adetailed
description of the methods used to construct the A~*genes and to transfect the genes into M12.C3
cells is given elsewhere (9).
in thela gene-transfected, neomycin-resistant bulk populationswasevaluatedthrough
quantitative immunofluorescence by staining with AQ-, Ad-, or A6-reactive InAbs.
Most of the 14 cell populations resulting from the transfection ofAp* genes encoding
single d allele residues at different positions express A6* Ad molecules on the cell
surface at a level comparable to that obtained from cells transfected with the wild-
type Ah gene (9, data not shown). M12.C3 cells transfected with awild-typeAa gene
and a mutant Ah* gene encoding a polypeptide containing the substitution of a
single d allele residue at positions 78 or 86 (mutantAh* genes are designated M.78
or M.86, while transfected cells are designated T.78 or T.86, respectively) express
normal levels of cell surface A~* Aa molecules. However, M12.C3 cells transfected
with only the M .78 or M.86 Ah* genes (transfected cells are designated 7780 and
T860, respectively) do not express detectable levels of AD* Ad molecules on the cell
surface (Fig. 2 a). Additional experiments indicated that the alteration of A6* Ad
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Expression ofA~*AQmolecules after
transfection of Af* genes into M12.C3 cells. (a)
Immunofluorescence profiles ofneomycin-resistant
bulk populations after surface staining with the
AQ-reactive mAb K24-199. M12.C3 cells trans-
fected with the M.78Ah* or M.86Ak*gene
transfected with the M .13 Ah* ene (-); trans-
fected with the M.65-67, 784*gene
￿
or
transfected with the wild-type Ah gene (
￿
-).
For each ofthe cell populations the flourescence
profile obtained with an isotype-matched control
antibody (H13A21) wassuperimposable with the
profile illustrated for cells transfected with the
M.78 A*' and M.86 Ah* genes. (b) Immunoflu-
orescence profiles after surface staining with the
A~-reactive mAb40F. See a for key to symbols.
The negative control antibod treatment wasin
distinguishable from M.78
￿
andM.86~*An y'.
Previous studies have demonstrated that binding
of the mAb 40F is not altered detectably by the
substitutions encoded by these transfected Ah*
genes (9).826
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cell surface expression in these cells was not due to ineffective transfection of the
M . 78 orM.864* gene. Supertransfection of the Aa gene and a hygromycin resis-
tance marker into T78 R andT86 a which expressed Ap* and Ad mRNA, resulted
in high levels ofAp* Aa cell surface expression as determined by staining with Ap-
or AQ-reactive antibodies (our unpublished results) . When T860 bulk cultures were
cloned, cells were found by flow cytometric analysis that expressed very low levels
of T86 Ap* Ad molecules on the cell surface (<5% of the level expressed by wild-
typeTAk R cells based on mean peak channel fluorescence values ; data not shown) .
In contrast, no cell surface la molecules were detected on cloned T78 0 cells . These
results demonstrate that the substitution of a single d allele residue at position 78
or 86 in the Ak Pi domain either inhibits completely or nearly completely the cell
surface expression of the Ap* Ad molecule but does not impair surface expression
of the Ap* Aa molecule .
Since wild-type Ag and A$ polypeptides pair efficiently with each other (5), we
anticipated that additional d allele substitutions in the Ap* Pi domain might correct
the surface expression defect caused by single d allele substitutions at positions 78
or 86 . Evidence for such intragenic complementation was observed when an AP
gene containing dallele substitutions at positions 65-67 and 78 was transfected into
MUM cells (T65-67, 78 a) . Quantitative immunofluorescence analysis of the re-
sulting bulk population demonstrated that the T65-67, 78 Ak* polypeptide is ex-
pressed, albeit inefficiently, with the Ad polypeptide (Fig. 2, a and b) . To rule out
the possibility that the relatively low level ofT65-67, 78 Ap* Aa cell surface expres-
sion is due to inefficient transfection, we compared levels ofAp* Ad surface expres-
sion with Ap mRNA levels in the cloned lines T65-67.78 a and TAk a expressing
the M.65-67, 78 Ap* A« molecule or the wild-type Ap A« molecules, respectively.
Although the T.65-67, 780 cells express lower amounts ofAp* Ad molecules on the
surface than the wild-typeTAk a cells, the T65-67, 78(3 cells express two to three
times higher Ak* mRNA levels (Fig . 3) .
FIGURE 3 .
￿
Quantitation of Ap-specificmRNA from cloned cell lines
expressing theAp*AQ molecule. Poly(A)' mRNA from each cell line
was hybridized sequentially with synthetic olirnucleotides derived
from the noncoding strand oftheAA gene, theAa gene, or actin . Lane
1, M12.C3 ; lane 2, TA D ; lane 3, T65-67, 78 0 ; lane 4, T13 P .BUERSTEDDE ET AL.
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To examine this question further, AP genes containing multiple d allele regional
substitions in the 01 domain (see Fig. 1 for boundaries of regions) were transfected
into M12.C3 cells. The construction and serologic characterization of these AP
genes was described previously (9). Whereas cells transfected with Ak* genes con-
taining d allele residues in regions C or CD do not express A4* Ad molecules on
the cell surface, M12.C3 cells transfected with AA* genes containing dallele residues
in D, ABC, ACD, BCD, or AC express high levels of AA* Ad complexes on the cell
surface (Table 1). The cell surface expression of AA* Aa molecules by cells trans-
fected with theAb gene containing the region D substitutions (TD 0 cells) indicates
that the addition ofdallele residues at positions 83 and/or 84 correct the cell surface
expression defect observed in the T86 0 mutant. Additional substitutions in the B
region are also corrective (compare T.BCDO with T.CDO). Thus, while the substi-
tution ofd allele residues at positions 78 or 86 resultsin either no detectable or very
low levels of Aft* Ad cell surface expression, the A~* Ad molecule can be expressed
at varying degrees of efficiency if the A4* polypeptide contains additional d allele
residues in other regions of the 01 domain.
Analysis of T . 78 P and T .86 0 Cellsfor Expression ofAh* Aa Molecules Intracytoplasmi-
cally. The observation that T78 0 and T86 0 cells express cell surfaceAh* Ak mole-
cules after they are supertransfected with theA'agene suggested that T780 and T860
cells might express the Ah* polypeptides that do not associate stably with Ad
molecules intracytoplasmically. To evaluate this possibility, detergent lysates of
[
35S]methionine T78 0 and T86 0 cloned cells were immunoprecipitated with an
anti-Ah mAb and the immune complexes were analyzed by two-dimensional gel
electrophoresis. Although spots comigratingwith AA, A«, and invariant (Ii) polypep-
tides were isolated from the T86 0 anti-A6 immunoprecipitates, the migration pat-
tern of the polypeptides isolated from the T86 0 la preparation was different from
the pattern observed with the wild-type la preparation (Fig. 4). In the wild-type
anti-Ak k immunoprecipitate, the Ak polypeptide migrates as two major spots: a lower
molecularweight precursorform and a higher molecularweight, more anionic spot
that contains additional complex sugars and aterminal sialic acid residue. The T86
As* polypeptide migrates predominantly in the precursor form, with a small pro-
portion of the molecules migrating as the higher molecular weight, mature form.
Similarly, the T.86 0 la preparation contains an Aa polypeptide that migrates
predominantly as the core-glycosylated form, with a relatively small proportion of
the molecules in the higher glycosylated, more anionic forms. The T86 la im-
munoprecipitate also contains relatively large amounts of highly sialyated Ii poly-
peptides as compared with the Ia polypeptides isolated from the wild-type TAk 0
cells. This result is consistent with previous observations that intracytoplasmic
precursor la molecule preparations contain more Ii polypeptide than Ia molecules
isolated from the plasma membrane (20, 21). When comparisons are made of the
numbers of T86 0 cells and TAk 0 cells used in these experiments, the autoradio-
graphic exposure times, and theintensity ofthe a and 0 spots from the two prepara-
tions, the results suggest that the T86 0 cells and the TAk 0 cells'contain comparable
amounts of Ap Ad polypeptides. Although quantitative immunofluorescence results
suggest that theseT.86 0 cells express <517o ofthe amounts ofcell surface Ia as com-
pared with the TAk 0 cells, anti-A4 immunoprecipitates from the T.86 0 lysates con-
tain much more than 5% of the T86 Ak h* or Aa molecules in the highly glycosylated,828
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mature forms. Together these results suggest that T86 A~* Aa molecules are not
being transported efficiently to the cell surface and that these la molecules are ac-
cumulating within the cytoplasm.
Two-dimensional gel analysis of anti-A4 immunoprecipitates from ["S]methionine
T78 0 cell lysates demonstrated the presence of acomplex comprising the core-gly-
cosylated T .78 A4* polypeptide and the core-glycosylated Ii polypeptide (Fig. 4).
No Aa polypeptide was detected in the T78 0 Ia preparation. Thus, although the
T.78 A~* polypeptide does not associate stably with the endogenous Aa polypeptide,
it does associate with the Ii polypeptide. Since the T78 A~* and Ii polypeptides are
found exclusively in their precursor forms, it is likely that this A~* Ii complex is
located within the endoplasmic reticulum. Although little is known about the re-
quirements for Ii polypeptide association with the Ia a/S complex, theseresults dem-
onstrate that the Ii polypeptide is capable of associating with the A¢ polypeptide
in the absence of the A« polypeptide.
Altered Cell Surface Expression of T .13 A~* Aa Molecules.
￿
Transfection of the M.13
Ah* gene resulted in low levels of cell surface expression of the T13 A~* Aa mole-
cule on the T.13 R bulk cell population (Fig. 2 a). This low level of detectable cell
surface expression of the T13 AO* Ad molecule could be due to a mutation-induced
alteration of the serologic epitope resulting in a change of affinity of the AA- or Aa-
reactive mAbs for the T.13 M* Aa molecules rather than a quantitative alteration
in the level of expression of the T13 AA* Ad molecules. As shown previously by
Braunstein and Germain (8), the relative affinity ofan anti-la antibody for different
AD Aa molecules can be evaluated by quantitative immunofluorescence analysis
using increasing dilutions of the mAb. When the antibody is limiting, the fluores-
cence intensity of an Ia-bearing cell line is dependent primarily on the affinity of
the antibody for a specific epitope. When such an analysis is performed with in-
creasing dilutions of 40F mAb (anti-Ap), the T130, wild-type TA' a andwild-type
TA3 cells stain equivalently (Fig. 5 a). These results suggest that the low level of
T.13 AA* Aa cell surface expression is not due to a mutation-induced alteration in
antibody affinity. Northern blot analysis of a cell line cloned from this bulk popula-
tion (T13P) demonstrated that the low level of T13 AD* Ad expression is not due
to inefficient transcription of theM.13 A~* gene. As shown in Fig. 3, the T.13a cell
line expresses more A~ mRNA than the wild-type transfected TAk p cell line, al-
though surface A~* A« expression is lower in the T13 0 cell line.
NHZ-terminal AA_ Residues Regulate Ak* A« Cell Surface Expression.
￿
To identify the.
polymorphic residues in the AA Pi domain that are important for Ap Ak surface ex-
pression, Ah* genes encoding one or more d allele residues in the Pi domain were
cotransfected together with the wild-type Ak gene into M12.C3 cells. Quantitative
immunofluorescence analyses with AA-, Aa-, or Aa-reactive mAbs demonstrated
that, with the exception of the cases noted below, expression of Ah* Ak a molecules
in the bulk populations transfected with the Ak* and Aa gene is comparable to ex-
pression of A~ A« molecules in the bulk population transfected with the wild-type
A~ and Aa genes (9 and our unpublished results). In addition, cell lines generated
from these bulk populations express high levels of A4* Ak amolecules, but low levels
of V Aa molecules, as determined by surface staining with Aa- or Aa-reactive
mAbs (9). Transfection of the AQ gene together with the Ak* gene encoding d allele
residues in region A (TA.) (see Fig. 1) did not result in cell surface expression of830
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theTA A~* Aa molecule (Fig . 6, Table I) . However, M12.C3 cells transfected with
only theMA Ah* gene do express high levels ofTAAg* Aa molecules on their cell
surface (9) . Theseresults confirm previous studies that localized thepositions respon-
sible for preferential a/0 chain association to the NH2-terminal half of the 01 domain
(7) and further localized these residues to positions 9-17 .
Surface expression ofthe A~* Aa molecule in bulk populations and cell lines trans-
fected with A# genes encoding a polypeptide substituted with a single dallele residue
at either position 12 or 13 and wild-type Aa genes has been shown previously to be
impaired (9). Flow immunocytometric analysis was used to determine if the substi-
tutions at position 12 or 13 altered the relative affinity of the anti-Aa mAb 39J for
T12 or T13 Ap* Aa molecules (Fig . 5 b) . Although the T13 cells express relatively
small amounts of cell surface Ia, the fluorescence curve obtained with cloned T13
E
C
U
1,000
Log fluorescence intensity
39 J
FIGURE 5 .
￿
Comparative analysis ofthe rela-
tive affinities of(top) 40F or (bottom)39JmAbs
for wild-type. (Top) Anti-Ah-reactive mAb
40F on wild-typeT.Ak0(A AQ) cells, T.12p
(Ah* Aa) cells, and T13p (A * AQ) cells . Each
point represents the mean fluorescence level
obtained from the transfected cells stained
with acomparable dilution ofan inappropriate
mAb from the mean fluorescence level ob-
tained from the transfected cells stained with
39J or 40E (Bottom) Anti-Aa-reactive mAb
39Jon wild-typeTAk~AA Aa) cells, T12 (Akp*
Aa) cells, and T13 (Ap* Ak u) cells .
FIGURE 6.
￿
Quantitative immunofluorescence
profiles ofhygromycin-resistant bulk popula-
tions after surface staining with theAk u-re-
active mAb 39J . The wild-type Aa gene and
a hygromycin-resistance marker were trans-
fected into T12p cells (-), T13p cells (- -),
wild-type TAk p cells ( . . . . . .), or TA p cells
(---) . The profile obtained with the isotype-
matched control antibody was superimposable
with the profile obtained with 39J on theTA
p cells.BUERSTEDDE ET AL.
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TABLE I
Surface Expression of Ah* Aa and Ah` Aa Molecules After Transfection of
M12. C3 Cells with Wild-Type Aa Genes and/or Ah
Genes Encoding d Allele Regional Changes
Cell lines
T.A. T.ABC T.AC T.ACD T.BCD T.CD T.C. T.D.
Ad AB"$
￿
+
￿
+
￿
+
￿
+
￿
+
￿
-
￿
-
￿
+
Aa Ag*§
￿
-
￿
-
￿
-
￿
-
￿
+
￿
+
￿
+
￿
+
Results provided in this table represent a summary of previously reported quan-
titative immunofluorescence analysis on transfected bulk populations using a
panel of A~-, Aa-, and Ad-reactive mAbs (9). Expression level designation :
(-) <5% of the mean peak channel fluorescence obtained with the M12 .C3
cells transfected with wild-type Aa and Aa genes (T.A-K cells); (+) mean peak
channel fluorescence comparable (t 20%) to the profile obtained with wild-
type T.A-K cells.
1 Cells resulting from transfection of a mutant Ak* gene.
3 Cells resulting from transfection of a AB* gene plus wild-type Aa gene.
A~* Ak a cells does not differ significantly from the curve obtained from cloned cells
expressing either T12 A~* Ak or the wild-type TAk molecules. This analysis was
repeated three different times with comparable results. These results indicate that
the single d allele substitution at either position 12 or 13 does not alter our ability
to detect the T12 or T13V Ak molecules.
To determine if these altered levels of Ap* Aa surface expression are caused by
variation in the amount of Ajl* mRNA expression, we identified cloned cell lines
expressing the Aa gene and similar levels of either the M.12, M.13 or wild-type AD
mRNA (T12B, T130 and TAk R [2] [clone 2], respectively) for further analysis.
These cell lines were supertransfected with the wild-type A« gene together with a
hygromycin resistance marker (14) . Immunofluorescence profiles of the three hygro-
mycin-resistant bulk populations demonstrated that Ap* Aa surface expression is
lower in the cells transfected with the M.12 Ap' or M.13 Ap' gene than the AD Aa ex-
pression in cells transfected with the wild type AP and Aa genes (Fig. 6). Northern
blot analysis of cell lines cloned from these bulk populations demonstrated that the
low level of Ap* Aa expression is not due to inefficient transcription of theA gene.
As shown in Fig. 7, the cell lines expressing the T12 Ap* Aa (lane 3) or T.13 AD
Ak molecules (lane 4) contain more Aa specific mRNA (relative to levels of actin
mRNA) than the cell line expressing the wild-type AD Aa molecule (lane 2), al-
though Ap* A« surface expression is lower in the former cell lines. These results sug-
gest that the absence of cell surface expression of the TA Ap* Aa molecule may be
due primarily to the additive effects of substituting d allele residues at positions 12
and 13 . In contrast to what was observed with the T78 or T86 AD mutants, no ad-
ditional d allele substitutions in the AD polypeptide are corrective for the observed
defects in T.A Ap* Aa cell surface expression (Table 1).
Discussion
A panel of Ak* mutants, which contain one or more d allele residues in the (31
domain, have been used to identify 01 domain polymorphic positions that are respon-832
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FIGURE 7 .
￿
Quantitation ofAa k,-specificmRNA from cells cloned from
the hygromycin-resistant bulk populations . Poly(A)' mRNA from
each cell line was hybridized sequentially with synthetic oligonucleo-
tides derived from thenoncoding strand of the Aka gene, the A~ gene
or actin . Lane 1, M12.C3; lane 2, wild-typeTAk p cells transfected
with the Ak gene ; lane 3, T.120 cells transfected with the AQgene; and
lane 4, T13S cells transfected with the Ak gene.
sible for the altered cell surface expression of the AD polypeptide with either the Aa
polypeptide or Aa polypeptide . The substitution of d allele residues in the NH2-
terminal end of the Ap* (31 domain (region A; polymorphic residues 9, 12, 13, 14
and 17) results in the complete absence of detectable TA Ap* Aa complexes within
the transfectedMUM cells . Although the substitution of d allele residue at any
one of these five positions does not result in the complete absence of Ap* Aa cell
surface expression, substitution at either positions 12 or 13 impairs significantly the
expression of Ap* Aa molecules . The affects of the substitutions at these two posi-
tionsmay be additive and together be responsible for the complete loss of expression
observed with the TA Ap* Aa mutant . The expression defect resulting from the sub-
stitution ofdallele residues in regionAcannot be overcome by the addition ofother
d allele residues at other positions in the Pi domain (9) . Although we have analyzed
these mutants with anti-AamAbs that are reactive to two different Aa serologic epi-
topes, we cannot completely rule out the possibility that our inability to detect this
A0* Aa molecule is because the (31 domain substitutions alter the Aa serologic epi-
topes . These results are consistent with a previous report demonstrating that the
polymorphic residues in the NH2-terminal half of the 01 domain were responsible
for inhibiting the expression of the AD Aa molecule (6, 7) . Our results demonstrate
that there are a minimun oftwo and amaximum of five NH2-terminal polymorphic
residues that may alter the conformation of the Ag polypeptide, such that it will not
interact effectively with the Aa molecule to produce the hybrid A Aa molecule .
The substitution of a single d allele residue at position 86 in the Ap polypeptide
results in the expression of very low levels of the mutant T86 Ap* Ag molecules on
the cell surface . Analysis of theT86 R Ia complexes on two-dimensional gels demon-
strated that although the highly glycosylated, mature forms of both the T86 Ap*
and Aa polypeptides are present, a large proportion of these two polypeptides mi-
grate in positions corresponding to the less glycosylated precursor forms . However,
the two-dimensional gel analyses also indicate that both T86 a cells and wild-type
cells express comparable levels of a/a complexes . Together these results suggest that
the T86 Ap* Ad molecules are not being transported properly to the cell surface
and are accumulating in an intracellular compartment . Ii polypeptide, which hasBUERSTEDDE ET AL.
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been hypothesized to be involved in the intracellular transport of Ia molecules (20,
21), is associated with the T.86 Ap* Aa complex and is not likely responsible for the
altered Ia expression. It is possible that the T86 substitution produces a subtle alter-
ation in a-a or a-R-Ii association, which might result in abnormal rates of degrada-
tion ofthe Ap* Aa molecules intracellularly. Studies are in progress to evaluate this
possibility.
The presence of sialic acid-mediated charge heterogeneity on the T .86 AD*, Ad
and Ii polypeptides indicates that at least aportion ofthe T86 Ia molecules arebeing
transported intracellularly to the trans cisternae ofthe Golgi apparatus (22). Previous
reportshave indicated that the routingofproteins to the lysosomes, secretory storage
vesicles, or to the plasma membrane appears to be regulated within the Golgi stack
(23) . Results from several model systems have suggested that proteins destined for
theplasma membrane are unselectivelytransported from the Golgi apparatus, while
routing to the secretoryvesicles or lysosomes requires some sort ofsignal, presumably
encoded within theprotein's sequence (24-27). The alteredexpression observed with
T86 a mutants could result if the dallele substitution at position 86 either creates
a signal that causes the Ap* Aa molecules to be retained in the Golgi apparatus (or
routed to the lysosomes) or alters a signal that is responsible for transporting the
Ap* A« molecule to the cell surface. At this time we do not have sufficient experi-
mental data to distinguish this signal-mediated regulation ofclass II expression from
a potential a/R chain pairing defect in these mutants.
Griffith et al. (28) have reported two other in vitro immunoselected Ia mutants
that exhibit a mutation and pattern of expression similar to what is observed with
T86 R. M12M and M12.A2 cell lines express Ed and Ad molecules, respectively,
that are expressed intracytoplasmically but not on the plasma membrane and con-
tain sialic acid-mediated charge heterogeneity on their a, Ii, and/or 0 polypeptides.
The altered phenotypes are due to point mutations (Asn -" Ser) at position 83 in
the M12.C3 E9 molecules or position 82 in the M12.A2 A9 molecules. It was specu-
lated that the MUM and M12.A2 R chain mutations may have altered a positive
transportsignal that is needed to direct theIa molecule to the cell surface (28). This
transport signal was predictedto comprise five amino acids between residues 79 and
83, which are conserved in almost every known class 11 0 polypeptide. If the muta-
tion in the T86 S la molecules alters the same transport regulatory mechanism that
is responsible for the altered transport of the M12M and M12.A2 Ia molecules,
then additional constraints need to be made on the putative transport signal hypoth-
esis proposed by Griffith et al. (28). The 86 substitution occurs outside thepreviously
designated boundaries of the hypothesized signal sequence and, most importantly,
functions in an allele-specific manner (i.e., the T86 Ap* polypeptide is expressed
normally with the Aa polypeptide but not with the Aa polypeptide). Thus, if aposi-
tive (or negative) transport signal is located in this region of the (31 domain, then
the signal must either be altered by or comprise, in part, polymorphic residues in
the AQ polypeptide. Since the substitution of additional d allele residues in the (i1
domain corrects the expression defect, it is likely that a putative signal would be
conformationally determined. The substitution ofdallele residues at the polymorphic
position 86 or the apparent random substitution at the nonpolymorphic positions
82 or 83 in the4 or E9 sequences, respectively, may be responsible for creating
a similar expression phenotype. It therefore seems most likely that the mutations834
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may have altered the conformation ofthe la molecule (resulting in rapid degrada-
tion of the molecule) rather than altered a signal responsible for the transport of
the Ia molecules from the Golgi apparatus.
Although the T86 As* A« molecules are expressed at very low levels on the cell
surface, the Ap* polypeptides containing d allele residues at positions 85, 86, and
89 (region D) are expressed normally with either Aa or Aa polypeptides. Thus, in-
terallelic conversion ofcertain stretches ofamino acids, rather than single substitu-
tions, mightbe selected evolutionarily becauseoftheresultingfunctional consequences
ofthe altered a/a surface expression. The fact that the altered expression resulting
from at least one other chemically conservative substitution (e.g., val - ala at posi-
tion 78) is more difficult to correct by the addition ofmore d allele residues (TCR
and T.CD(i are not expressed with AQ, while TAC, T.ACD and TBCD are) may
be because position 78 is critical for maintaining Ap* Ad or As* Ad Ii chain associ-
ation. Sequence analyses ofmurine and human Q chain genes have shown that the
region around residue 78 is conserved evolutionarily. Our results with the T78 R
cells suggest that there may be significant constraints on the potential mutations
that can occur in this region of the R1 domain.
Bjorkman et al. (29, 30) have reported the crystal structure of a human class I
molecule. Residues in the al and a2 domains form a platform comprising an eight-
stranded a-plated sheet topped by two a helices, which together form a grove that
is believed to be the recognition site for processed antigen. Brown et al. (31) have
recently used the class I crystal structure to model the three-dimensional conforma-
tion ofa class II al 01 domain. In this model, region A ofthe 01 domain is predicted
to be located in the bottom of the groove between the two a helices. Since region
A is predicted tobe located in the middle of a Q strand that is adjacent to a R strand
that comprised the NH2 terminus ofthe a chain, the introduction ofd allele residues
into region A of the Ap polypeptide could disrupt the interaction of these two R
strands, resulting in destabilization of the a/(3 complex. Residue 78 is predicted to
be located on one ofthe two a helices at a pointjust above a R strand, which com-
prises the NH2-terminal region of the 01 domain. The side chain ofresidue 78 is
predictedto point inwards, toward the groove that contains the hypotheticalantigen
binding site. In this orientation, it would not be adjacent to the a polypeptide or
be readily exposed on the exterior ofthe molecule in a site that could interact with
an exogenous transport molecule. Residue 86 is predicted to be near the end ofthe
same a helix, which contains residue 78, in a region whose conformation cannot
be predicted from the class I molecule structure. Thus, although this hypothetical
model ofthe class II structure supports the ideathat the substitution ofdallele residues
in region A disrupts a/R chain association, it does not help us to determine why
the substitution of d allele residues at positions 78 and 86 alter the cell surface ex-
pression of the Ap* Ad molecule.
In a previous report from this laboratory we demonstrated that the majority of
the known Ap- and Ag-characteristic serologic epitopes are not affected by substi-
tutious of polymorphic residues in the NH2- or COOH-terminal regions but can
be localized to the polymorphic positions 40, 63, and 65-67 (9). These results sug-
gested that these three serologically immunodominant positions are exposed on the
exterior ofthe molecule and may be spatially adjacent. The results reported here
further define the model ofthe I-A molecule by identifying Ap and M polymorphicBUERSTEDDE ET AL.
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residues in both the NH2- and COOH-terminal regions of the 01 that may interact
with Aa polymorphic residues and/or other potential intracellular transport mole-
cules to determine a//3 chain cell surface expression.
Summary
A panel of mutant class II genes have been constructed using site-directed muta-
genesis and DNA-mediated gene transfer. Using this technique, A~ polypeptides
have been altered by substituting one or more Ag-specific residues at polymorphic
positions in the 01 domain. Transfection of M12M B lymphoma cells with most
mutant Ap* genes results in the expression of Ap* Aa molecules on the cell surface.
However, the substitution of a single dallele residue at position 78 or 86 in the AD
polypeptide results in either the complete absence or very low levels, respectively,
of cell surface expression of the AD* Ad molecule, but does not alter AD* Aa expres-
sion. The T86 Ap* Aa is expressed primarily in an intracellular compartment while
the T78 AD* Ad molecule does not appear to be produced. The core-glycosylated
T78 Ap* polypeptide does, however, form a complex intracellularly with the core-
glycosylated Ii polypeptide. Substitution of the combination of d allele residues at
Ap polymorphic positions 9, 12, 13, 14, and 17 results in the absence of Ap* A« cell
surface expression but does not alter the expression of this mutant Ap* polypeptide
with the A« polypeptide. These allele-specific expression mutants demonstrate that
substitution at certain 01 domain positions may result in the alteration of Ia cell sur-
face expression and that the transport of la molecules from the Golgi apparatus to
the cell surface may be regulated by signals that are determined by the interaction
of polymorphic residues in both the a and R polypeptides.
Received for publication 4 April 1988.
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